<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95843">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01999556</url>
  </required_header>
  <id_info>
    <org_study_id>LCI-HEM-SPEC-001</org_study_id>
    <secondary_id>00008179</secondary_id>
    <nct_id>NCT01999556</nct_id>
  </id_info>
  <brief_title>LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia</brief_title>
  <official_title>LCI-HEM-SPEC-001: Tissue Collection for Familial Acute Myelogenous Leukemia Genetic Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Belinda  Avalos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carolinas Healthcare System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain high quality specimens for molecular studies for the
      identification and characterization of genetic mutations involved in the pathogenesis of
      familial myeloid malignancies. Specimens obtained will be de-identified, linked to basic
      clinical data, and sent to Washington University (Division of Oncology, St. Louis, MO) for
      molecular analyses. Some specimens sent to Washington University may also be used for
      quality control analyses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a specimen collection study for patients receiving standard of care treatment for
      AML. Specimens collected will be 1) bone marrow biopsy and aspiration, 2) peripheral blood,
      3) skin punch biopsy, and 4) oral rinse. Collection of these specimens will be at timepoints
      determined by the patient's standard of care and their physician Investigator.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of participants with the mutation for acute myelogenous leukemia.</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Leukemia, Myelogenous, Acute</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <description>Specimen Collection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Relative</arm_group_label>
    <description>Specimen Collection</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients must have a diagnosis of acute myelogenous leukemia. Family members of patients
        with acute myelogenous leukemia may be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Patients must have a diagnosis of  acute myelogenous leukemia.

          -  Family members of patients with acute myelogenous leukemia may be enrolled.

          -  Informed consent must be provided by the patient or his/her legal guardian in accord
             with the practices of Levine Cancer Institute and Carolinas Healthcare System.

        Exclusion Criteria

          -  Known infection with Hepatitis B or C, HTLV, or HIV.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Belinda Avalos, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolinas Healthcare System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nena C Golembe</last_name>
    <phone>980-442-2336</phone>
    <email>Nena.Golembe@carolinashealthcare.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Levine Cancer Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Belinda Avalos, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 2, 2013</lastchanged_date>
  <firstreceived_date>November 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Carolinas Healthcare System</investigator_affiliation>
    <investigator_full_name>Belinda  Avalos</investigator_full_name>
    <investigator_title>Belinda Avalos</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
